Organic dust is known to be involved in the pathogenesis of hypersensitivity pneumonitis. Diagnosis is based on characteristic clinical symptoms and demonstration of antigen-specific IgGs (1) (2) (3) (4) . Antigen exposure also elicits production of IgGs in other pulmonary diseases, such as invasive aspergillosis (5, 6 ) , allergic bronchopulmonary aspergillosis (ABPA) 3 (7 ) , and ABPA in cystic fibrosis (8 ) . A widely used method to detect specific IgG in clinical laboratories is the immunoprecipitation technique. However, detection of precipitating antibodies has disadvantages. Specificity (9 ) and sensitivity (10, 11 ) are limited, reproducibility is poor, and antibody concentrations cannot be measured (11 ) . Moreover, this method is timeconsuming and therefore not recommended for routine purposes (11, 12 ) .
Other immunodiffusion assays, such as counterimmunoelectrophoresis (5 ) and radioimmunoprecipitation (13, 14 ) , are more rapid tests with lower detection limits than the precipitation technique. Although ELISA was shown to be even more sensitive and reliable than immunodiffusion (9, 10, 15 ) , its suboptimal specificity can lead to false-positive results, identifying clinically irrelevant IgG responses.
Recently, an automated technique for detecting specific IgG has become available on the ImmunoCAP system (Sweden Diagnostics). Agreement between specific IgG determination on ImmunoCAP and the precipitation tech-nique has been reported in a limited number of selected patients (12, 16 ) , but data on the performance of ImmunoCAP in a routine clinical setting are lacking.
In this study, we evaluated the diagnostic performance of ImmunoCAP for detecting antigen-specific antibodies. The distributions of IgG specific to A. fumigatus and pigeon antigens was determined in a healthy nonexposed control population and in different groups of patients with well-defined pulmonary diseases. The results were compared with results obtained with the precipitation technique.
Materials and Methods study population
We collected sera from 42 healthy female laboratory technicians, ages 25-61 years, who had no history of allergy to A. fumigatus or avian antigens and no contact with birds. Over a 1-year period, (January 2004 to January 2005), we also collected sera from 223 consecutive patients from the Departments of Internal Medicine and Paediatrics to ensure a random sampling. For these serum samples, we determined serum precipitins against A. fumigatus and/or pigeon serum antigens. Also included in the study were 42 stored patient sera, collected over a 2-year period (January 2003 to December 2004), with a high number of precipitation lines (Ն4) for one or both antigens. Samples from 56 patients were excluded because medical data on the patients were not available. For all patients included in the study, there were no indeterminate or missing results. We tested 219 patient sera for A. fumigatus antibodies [98 males (ages 2-91 years; median, 24 years) and 92 females (ages 4 -83 years; median, 24.5 years)], and 46 sera for pigeon antibodies [9 females and 37 males (ages 21-81 years; median, 66 years)]. Performing the study had no adverse effects on the participants.
precipitation technique
Extracts. A. fumigatus strain BC 192.65 was obtained from the Centraal Bureau voor Schimmelculturen (Baarn, the Netherlands) and grown on Sabouraud agar (Sanofi Diagnostics Pasteur) for 5 days. Afterward, the fungus was grown by shaking in 250 mL of Czapek-Dox broth with an initial pH 5.0 in 1-L flasks at 37°C for 3-4 weeks (17 ). The culture filtrate was separated from mycelia by passage through Whatman no. 4 paper. Filtrates from different flasks were pooled and dialyzed against distilled water at 4°C (relative molecular mass cutoff, 10 000). The medium was freeze-dried and reconstituted at a concentration of 250 g/L in distilled water.
Lyophilized pigeon serum was obtained from Hal Laboratories. Before use, it was dissolved in 1 mL of distilled water at a concentration of 30 g/L.
Procedure. The test was performed by standard Ouchterlony technique (18 ) 
evaluation details
Specific IgG was determined on frozen material after collection of all samples. Within-assay and between-assay variability were calculated according to CLSI (formerly NCCLS) guidelines (19 ) . For both A. fumigatus and pigeon, 1 sample was assayed 20 times within the same run, and 2 samples were assayed in 20 different runs.
To investigate interference by lipids, samples were supplemented with different dilutions of a serum with high triglyceride concentration (9.09 g/L) as described previously (20 ) . The effect of hemoglobin was studied by adding increasing concentrations (up to 4.6%) of human hemolysate, as described previously (20 ) .
The reference standard was the clinical diagnosis. Data on diagnosis and exposure were collected retrospectively from the medical records. All medical records were reviewed by an experienced pneumologist. Diagnoses were based on criteria described by Denning (21 ) for aspergillosis, by Greenberger et al. (22 ) for ABPA, by the 2004 NIH report (23 ) for bronchial asthma, by Rosenstein et al. (24 ) for cystic fibrosis, and by Stevens et al. (25 ) for ABPA in cystic fibrosis (cystic fibrosis and ABPA). Another group consisted of patients with bronchiectases that were not the result of CF or ABPA. Other pulmonary diseases for which A. fumigatus antibodies were ordered by the physician were classified as "other pulmonary diseases". Diagnosis of pigeon breeder's disease was based on criteria of Richerson et al. (26 ) statistical analysis
The distribution of IgG concentrations was described by continuous summary descriptives (Analyze-it, version 1.62; Smart Software).
Differences in median concentrations of specific IgG were tested by the Mann-Whitney U-test. For differences in the number of precipitation lines, the 2 test was used; P Ͻ0.05 was considered significant.
ROC plot analyses were performed with Analyze-it.
Results linearity
Dilution of a sample with a high concentration of IgG to A. fumigatus (161 mg A /L) with sample diluent (0%-100% with increments of 10%) was linear (r ϭ 0.98), as was dilution of a sample with a high concentration of IgG to pigeon (178 mg A /L) (r ϭ 0.97). 
correlation between specifc IgG determination and the precipitation technique
The correlation between specific IgG concentrations and the number of precipitation lines is shown in Fig. 1 . Agreement between tests was 86% for A. fumigatus and 70% for pigeon antibodies (, 0.46, for both A. fumigatus and pigeon).
IgG antibody values among different patient groups
The median concentrations of IgG to A fumigatus and pigeon in healthy controls and in different patient groups are given in Table 1 .
IgG to A. fumigatus was determined in 219 patients with the following diagnoses: aspergillosis (n ϭ 10, comprising 9 patients with invasive aspergillosis and 1 with aspergilloma), ABPA (n ϭ 10), bronchial asthma (n ϭ 20), cystic fibrosis (n ϭ 112), cystic fibrosis and ABPA (n ϭ 11), bronchiectases not caused by cystic fibrosis or to ABPA (n ϭ 8), and miscellaneous pulmonary diseases, including chronic obstructive pulmonary disease (COPD) and pneumonia (n ϭ 48). (Table 1) . Except in patients with bronchial asthma, IgG concentrations were significantly higher than in controls but substantially lower than in patients with aspergillosis and ABPA (P Յ 0.001 for aspergillosis and P Յ 0.02 for ABPA). IgG concentrations in patients with aspergillosis were not substantially different from those in patients with ABPA (P ϭ 0.19).
We measured IgG to pigeon antigens in samples from 46 patients, including patients with pigeon breeder's disease (n ϭ 20), COPD (n ϭ 15), bronchial asthma (n ϭ 1), idiopathic lung fibrosis (n ϭ 5), pneumonia (n ϭ 1), infection (n ϭ 2), and other diseases (n ϭ 2). IgG was extremely high in patients with pigeon breeder's disease (median, 1024 mg A /L; 25th-75th percentiles, 484-1720). High concentrations of pigeon antibodies were also found in patients without pigeon breeder's disease (median, 445 mg A /L; 25th-75th percentiles, 25.75-1150) ( Table 1) . Differences were highly significant compared with healthy controls (P Ͻ0.0001 for pigeon breeder's disease patients and P Ͻ0.001 for patients without pigeon breeder's disease). Patients with pigeon breeder's disease tended to have higher antipigeon IgG values than patients without pigeon breeder's disease (P ϭ 0.07).
distribution of IgG antibody concentrations and diagnostic performance
The logarithmic distribution of A. fumigatus IgG in healthy controls, in patients with aspergillosis and ABPA, and in diseased controls (bronchial asthma, cystic fibrosis, cystic fibrosis and ABPA, bronchiectases, and other pulmonary diseases) is illustrated in Fig. 2 . Because IgG values in patients with aspergillosis and ABPA were comparable (Table 1 ) and because these are the medical conditions typically associated with the presence of antigen-specific antibodies, these 2 groups were taken together. All other patient groups were considered as diseased controls. There was a minor overlap between healthy controls and patients (aspergillosis and ABPA), but the majority of the patients had substantially higher antibody concentrations than the controls. Values obtained in diseased controls overlapped those for healthy controls and patients, with the greatest overlap with healthy controls. ROC curve analysis revealed areas under the curve of 0.957 and 0.859 for differentiating aspergillosis and ABPA patients from healthy individuals and diseased controls, respectively. The cutoff points with the highest sum of detection limit and specificity were 35.9 and 35.2 mg A /L, respectively, when healthy controls or diseased controls were taken as reference. At these cutoff points, the detection limit for detecting aspergillosis and ABPA was 90% (95% CI, 68.3%-98.8%). The specificities were 85.7% (95% CI, 71.5%-94.6%) and 65.3% (95% CI, 58.3%-71.9%), respectively, when healthy or diseased controls were considered. Recalculation of these data at a cutoff point of 70 mg A /L, corresponding to the 97.5th percentile of our healthy controls, produced a sensitivity of 70% (95% CI, 45.7%-88.1%) and a specificity of 97.6% (95% CI, 87.4%-99.9%). When diseased controls were considered as a control group, the specificity decreased to 85.9% (95% CI, 80.3%-90.4%). The number of patients with values above and below these cutoff points of 35 and 70 mg A /L are given in Table 1 . The distribution of IgG to pigeon antigens in healthy controls and in patients with or without (diseased controls) pigeon breeder's disease is shown in Fig. 3 . Controls had clearly lower pigeon antibodies than diseased people. All control individuals had IgG values Ͻ20 mg A /L to pigeon, whereas Ͼ89% of the diseased individuals had values Ͼ20 mg A /L. However, it was impossible to distinguish patients with and without pigeon breeder's disease on the basis of pigeon IgG concentrations (Fig. 3) . This finding was confirmed by ROC curve analysis. The area under the curve was only 0.614.
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influence of antigen contact on antibody production
To further explore the diagnostic utility of antipigeon IgG determination, we subdivided patients with and without pigeon breeder's disease on the basis of presence or absence of antigen contact.
The number of precipitation lines to pigeon serum antigens was clearly different between pigeon breeder's disease patients with and without current exposure (Fig.  4A) . Four of the 5 pigeon breeder's disease patients without active contact with pigeons had 1 or 0 precipitating lines. In pigeon breeder's disease patients with actual exposure, Ͼ80% had Ն4 precipitation lines. Fig. 4B shows the IgG concentrations to pigeon antigens in the same patient groups. The differentiation between IgG concentrations in pigeon breeder's disease patients with or without actual antigen contact was highly significant (P Ͻ0.002). All diseased patients without contact with pigeons had antibody concentrations Ͻ500 mg A /L, whereas patients with contact had concentrations Ն500 mg A /L, except for 1 patient receiving steroid therapy.
The number of precipitation lines and IgG concentrations in sera from patients without pigeon breeder's disease are shown in Fig. 4 , C and D. The patient subgroup with antigen contact had a higher number of precipitation lines (P Ͻ0.02), a finding that was even more pronounced when IgG concentrations were measured by ImmunoCAP. The antibody concentration in patients without pigeon breeder's disease without antigen contact (median, 27.35 mg A /L; n ϭ 10) was significantly lower (P Ͻ0.004) than in patients with antigen contact (median, 1060 mg A /L; n ϭ 13). Of the patients without pigeon breeder's disease and without antigen contact (n ϭ 10), 4 were former pigeon breeders. IgG concentrations in these patients were higher than in healthy controls. The antibody concentration in the other nonexposed patients without pigeon breeder's disease was, except for 1 patient, comparable to the concentration in nondiseased controls. Finally, we compared the number of precipitation lines and the concentration of IgG to pigeon between exposed pigeon breeder's disease patients and exposed patients with other pulmonary diseases. IgG titers to pigeon antigens in exposed pigeon breeder's disease patients (median, 1280 mg A /L; n ϭ 11) were comparable to the titers found in exposed patients with other pulmonary diseases (median, 1060 mg A /L; n ϭ 13) (P ϭ 0.41). Similarly, a comparable number of precipitation lines was found in both groups of patients (data not shown). Samples with a high number of precipitation lines had high IgG antibody concentrations with ImmunoCAP, and vice versa. However, a few samples without precipitating antibodies had rather high IgG values, and some samples with precipitating antibodies had low IgG values. Similar observations have been reported (11, 12, (27) (28) (29) and may be partly explained by differences in assay detection limit and quality and composition of the antigen extract. Indeed, pigeon serum antigen was used in the precipitation assay, whereas the antigen coupled to the ImmunoCAP contained proteins from serum, feathers, and droppings. Precipitating antibodies to A. fumigatus were reported as highly reliable in patients with aspergillosis (9 ) . Specific IgG is considered a major criterion for diagnosis of ABPA (8, 30 ) . We confirmed that aspergillosis and ABPA patients had high numbers of precipitating antibodies and high concentrations of anti-A. fumigatus IgG.
Discussion
Previous reports also described colonization with A. fumigatus in patients with cystic fibrosis (13, 31, 32 ) , COPD, and pulmonary infection (33) (34) (35) . All patient groups, except those with bronchial asthma, had substantially higher concentrations of specific IgG to A. fumigatus than did nondiseased controls but significantly lower concentrations than the aspergillosis and ABPA patient groups (Table 1) . At a cutoff point of 70 mg A /L, corresponding to the 97.5th percentile of the values obtained in 42 healthy, nonexposed controls, detection limit was 70% and specificity was 97.6% with healthy controls as a control group and 85.9% when diseased controls were considered. Hashemi (16 ) proposed a cutoff value of 126 mg A /L. The difference in cutoff values might be related to differences in exposure to A. fumigatus, a ubiquitous antigen, as also suggested by Makkonen et al. (36 ) , who found moderate IgG titers in healthy controls that indicated exposure to mold-derived antigens.
Precipitating antibodies and IgG to pigeon antigens were found in patients with pigeon breeder's disease. However, these antibodies were also found in many diseased patients without pigeon breeder's disease who had been exposed to pigeon antigen. Other investigators also found antibodies in sera of asymptomatic but exposed individuals (10 ) . Contact with antigen led to the production of high concentrations of anti-pigeon serum antibodies, meaning that no differentiation was possible between exposed individuals without pigeon breeder's disease and individuals with pigeon breeder's disease.
We collected data on exposure for every patient and found that contact with antigen was the most important variable related to antibody production. Patients with antigen contact had specific IgG values Ͼ500 mg A /L. Nonexposed control individuals had values Ͻ20 mg A /L. In comparison, Lopata et al. (12 ) reported a cutoff of 9.8 mg/L. Most patients without pigeon breeder's disease with values of 20 -500 mg A /L, including patients with dyspnea and COPD, had a history of contact with pigeons.
By the use of clinically well-defined patient groups in combination with data on antigen exposure, our study demonstrated agreement between the precipitation technique and the automated ImmunoCAP technique for the detection of antibodies to A. fumigatus and pigeon antigens. High concentrations of specific antibodies to A. fumigatus were found in patients with aspergillosis and ABPA. The presence of IgG antibodies to pigeon antigens indicates exposure to pigeons in individuals with or without pigeon breeder's disease.
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